COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,837 Articles (22,553 medRxiv, 8,284 bioRxiv)

Most recent first Previous |  Page 1253: Articles 12521-12530  | Next

Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells
Kapczynski, D. R., Sweeney, R., Suarez, D. L., Spackman, E., Pantin-Jackwood, M.
10.1101/2021.08.18.456916 — Posted: 2021-08-19
Neutralising antibodies against the SARS-CoV-2 Delta variant induced by Alhydroxyquim-II-adjuvanted trimeric spike antigens
Counoupas, C., Pino, P., Stella, A., Ashley, C., Lukeman, H., Bhattacharyya, N., Tada, T., Anchisi, S., Metayer, C., Martinis, J., Aggarwal, A., Dcosta, B., Kint, J., Wurm, M., Landau, N., Steain, M., Turville, S., Wurm, F., David, S., Triccas, J. A.
10.1101/2021.08.18.456891 — Posted: 2021-08-19
Integration of RT-LAMP and Microfluidic Technology for Detection of SARS-CoV-2 in Wastewater as an Advanced Point-of-care Platform
Donia, A., Shahid, M. F., Ahmad, A., Javed, A., Nawaz, M., Yaqub, T., Bokhari, H.
10.1101/2021.08.18.456880 — Posted: 2021-08-18
To share or not to share - What the general public thinks about global COVID-19 vaccine distribution
Klumpp, M., G. Monfared, I., Vollmer, S.
10.1101/2021.08.16.21262116 — Posted: 2021-08-18
Peripheral Artery Disease and COVID-19 Outcomes: Insights from the Yale DOM-CovX Registry
Smolderen, K., Lee, M., Arora, T., Simonov, M., Mena-Hurtado, C.
10.1101/2021.08.16.21262118 — Posted: 2021-08-18
Cap-independent translation and a precisely localized RNA sequence enable SARS-CoV-2 to control host translation and escape anti-viral response
Slobodin, B., Sehrawat, U., Lev, A., Ogran, A., Fraticelli, D., Hayat, D., Zuckerman, B., Ulitsky, I., Ben-Shmuel, A., Levy, H., Bar-David, E., Dikstein, R.
10.1101/2021.08.18.456855 — Posted: 2021-08-18
Interaction between spike protein of SARS-CoV-2 and human virus receptor ACE2 using two-color fluorescence cross-correlation spectroscopy
Fujimoto, A., Lyu, Y., Kinjo, M., Kitamura, A.
10.1101/2021.08.18.456769 — Posted: 2021-08-18
Protein-based RBD-C-tag COVID-19 Vaccination Candidate Elicits Protection Activity against SARS-COV-2 Variant Infection
Herrmann, A., Subramani, J., Shaabani, N., Shetty, D., Wu, H., Kwon, S., Li, W., Yue, C., Lahtz, C., Ramirez-Torres, A., Zhou, H., Zhang, Y., Allen, R. D., Farley, B., Emalfarb, M., Tchelet, R., Markku, S., Marika, V., Wiebe, M., Huuskonen, A., Ben-artzi, H., Avigdor, A., Ji, H.
10.1101/2021.08.17.456704 — Posted: 2021-08-18
An Endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells
Broadbent, L., Bamford, C. G. G., Lopez Campos, G., Manzoor, S., Courtney, D., Ali, A., Touzelet, O., McCaughey, C., Mills, K., Power, U.
10.1101/2021.08.17.456707 — Posted: 2021-08-18
Proactive COVID-19 testing in a partially vaccinated population
McGee, R. S., Homburger, J. R., Williams, H. E., Bergstrom, C. T., Zhou, A. Y.
10.1101/2021.08.15.21262095 — Posted: 2021-08-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).